Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

Harvard Medical School experts reported that a rapid loss of fat in the face can cause a hollowed look to the face; changes ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss drugs tirzepatide and semaglutide.